TipRanks
Infant Bacterial Therapeutics AB (DE:9IB)
FRANKFURT:9IB
Germany Market
9IB
Infant Bacterial Therapeutics AB
RESEARCH TOOLSreports

Infant Bacterial Therapeutics AB (9IB) Balance Sheet

4 Followers

Infant Bacterial Therapeutics AB Balance Sheet

Infant Bacterial Therapeutics AB's total assets for Q2 2026 were kr120.22M, a decrease of -15.99% from the previous quarter. DE:9IB total liabilities were kr67.20M for the fiscal quarter, a 11.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
kr 161.75Mkr 239.57Mkr 351.33Mkr 349.62Mkr 408.48M
Total Liabilities
kr 56.42Mkr 69.30Mkr 46.18Mkr 17.91Mkr 13.22M
Total Equity Gross Minority
kr 105.33Mkr 170.26Mkr 305.15Mkr 331.71Mkr 395.25M
Other Metrics
Currency in SEK

Infant Bacterial Therapeutics AB Debt to Assets